Volume 87 Issue 28 | pp. 16-17 | Concentrates
Issue Date: July 13, 2009

EC To Intensify Pharma Scrutiny

Department: Business
Keywords: European Commission, generic drugs, antitrust

The European Commission says it will intensify its scrutiny of anticompetitive practices in the pharmaceutical industry, particularly practices that hinder the introduction of low-cost generic drugs. An inquiry launched by the administrative arm of the European Union more than a year ago (C&EN Online Latest News, Jan. 17, 2008) turned up significant delays in the introduction of generics after original makers' patents expired. Neelie Kroes, commissioner for competition policy, says that the first antitrust investigations are already under way.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment